randomized double-blind placebo-controlled trial of acetyl-l-carnitine for als L-Carnitine in the Treatment Psychiatric and Neurological Manifestations: A Systematic Review Altered Bioenergetics and Metabolic Homeostasis
Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis ScienceDirect Randomised, double blind, placebo controlled, parallel group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with A multicenter, randomized, placebo controlled, double blind phase 3 trial with open arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome Kidney International randomized double blind placebo controlled trial of acetyl l carnitine for als The Scientific and Therapeutic Rationale OffLabel Treatments in Amyotrophic Lateral Sclerosis Bedlack 2025 Annals Neurology Liraglutide once daily versus placebo
Pay in 4 interest-free payments of $7.31 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



